J&J faulty implant: cops get data on 1,000 patients

Eight years after FIR against company, police reach out to patients to take statements

April 27, 2019 01:22 am | Updated 01:22 am IST - Mumbai

Nearly eight years after the Maharashtra Food and Drug Administration (FDA) registered a first information report against pharmaceutical giant Johnson & Johnson (J&J) for a faulty hip implant, the Mahim police have received a database of around 1,000 patients who were fitted with the implant. The police are now in the process of reaching out to the patients to take their statements.

“We have received data of 1,000 patients from Puri Crawford, the company hired by J&J to co-ordinate with the patients. We have started reaching out to patients who are in Mumbai as well as other parts of the country. In some cases, we have written to them,” said Ajinath Satpute, Assistant Commissioner of Police, Mahim division.

The metal-on-metal Articular Surface Replacement hip implant manufactured by J&J’s subsidiary DePuy Orthopaedics was recalled worldwide in 2010 following reports that it was leaching metal and causing severe pain, fluid accumulation and metal poisoning in patients. In India, nearly 4,700 surgeries were carried out using the faulty hip joint. The Maharashtra FDA was the first to acknowledge the issue and register an FIR on November 11, 2011 under Section 328 (causing hurt by means of poison) of the Indian Penal Code and several sections of the Drugs and Cosmetics Act that look at drugs not of standard quality or containing harmful or toxic substances that may render it injurious to health. However, till date, a charge sheet has not been filed in the case.

A Central expert committee has started computing compensation for patients based on aspects like the degree of disability, loss of wages, etc. So far, compensation for two patients has been announced. However, this has been challenged by the pharmaceutical company in the Delhi High Court.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.